[ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#provenance", "@graph": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-7641-6446" } ] } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#Head", "@graph": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "ZdOucn3Hz/j09uwy7a6lWABxotTAXQ9U2VcgxOyreBlPk204T7wV5QTeeMvHlFsBgA4Bq5tS+cYnCgGbMU/+VkSSQM5Iv87owSFJud35c2YUZMcWYUNl/1Fink4hEXelfDvDyz3xHonIbhcwflWZ5FVbIhPSOuzb6SYyQ5FErMs=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ" } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2022-09-16T11:50:59.318292", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1501-1082" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id": "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version": [ { "@value": "2.3.0" } ] } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#assertion", "@graph": [ { "@id": "http://identifiers.org/drugbank/DB00391", "@type": [ "https://w3id.org/biolink/vocab/Drug" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Sulpiride" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Drug" } ] }, { "@id": "http://purl.obolibrary.org/obo/MONDO_0005618", "@type": [ "https://w3id.org/biolink/vocab/Disease" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Anxiety disorder" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/MONDO_0005618" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "http://identifiers.org/drugbank/DB00391" } ], "@type": [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "First-generation antipsychotics (FGA) use was more than that of second-generation antipsychotics (SGA) use in patients with anxiety disorder through the 9-year period. Sulpiride and flupentixol were the two most common FGA in the treatment of anxiety disorder. Patients with specific anxiety disorder (post-traumatic stress disorder, panic disorder/agoraphobia, generalized anxiety disorder, and obsessive-compulsive disorder), female sex, younger age (age < 65 years), comorbidity with major depression or minor depression, antidepressants concurrent use, and visits to psychiatrists, medical centers and primary care were significantly more likely to take prescribed antipsychotics." } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source": [ { "@id": "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/has_population_context": [ { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#context" } ], "https://w3id.org/biolink/vocab/publications": [ { "@id": "http://www.ncbi.nlm.nih.gov/pubmed/31077503" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "http://purl.obolibrary.org/obo/NCIT_C94303" } ] }, { "@id": "http://purl.org/np/RAXOfRUa4ojduoBCsaa7y1jspzdDCSi39qhClLmlKLoBQ#context", "@type": [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Adults" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Cohort" } ] } ] } ]